I am a cancer health services researcher with long-term interests in cancer care delivery, survivorship, and patient-reported outcomes. My work implements rigorous quantitative and qualitative methods to identify, understand, and address healthcare delivery challenges for patients with cancer. For example, my recently completed NCI-funded K01 award (1K01CA251645) developed and evaluated a stakeholder-engaged intervention to support diabetes management for underserved patients with breast cancer undergoing active treatment. This 5-year grant involved in-depth interviews and focus groups with patients and providers to inform a multi-site intervention that is recruited 80 patients with breast cancer at NYP-Weill Cornell Medicine, Brooklyn and Queens.
To complement my intervention work, I lead a NCI-funded R37 (1R37CA288492) to determine drivers of long-term cardiovascular outcomes among cancer survivors in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study. This 7-year award leverages cancer registry data linked to a large epidemiologic cohort to study the influences of upstream structural factors on downstream intermediaries including individual behaviors (e.g., smoking, diet, physical activity), psychosocial well-being (e.g., anxiety, depression), and health service utilization patterns.
Biography
Dr. Laura Pinheiro, PhD, MPH, is an Associate Professor of Health Services Research in Medicine in the Division of General Internal Medicine at Weill Cornell Medicine. She also holds a secondary appointment in the Division of Epidemiology in the Department of Population Health Sciences. Additionally, she serves as the Co-Associate Director of Community Outreach and Engagement for the Sandra and Edward Meyer Cancer Center, and the Associate Director of Curriculum for the Cornell Health Equity T32 Research Fellowship. Dr. Pinheiro's research program focuses on improving access to high-quality cancer care delivery by rigorously evaluating real-world interventions to optimize health care delivery for underserved cancer patients.
Distinctions:
National Cancer Institute Cancer Moonshot Scholar
Donna Lamping Emerging Leader Award, International Society for Quality Research
